Back
Cidara Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
64
CDTX
Cidara Therapeutics, Inc.
Last Price:
$221.38
Seasonality Move:
-18.08%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and CDTX is experiencing slight buying pressure.
Cidara Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 221.38 | Sell |
| 20-day SMA: | 221.38 | Sell |
| 50-day SMA: | 221.17 | Buy |
| 200-day SMA: | 117.9 | Buy |
| 8-day EMA: | 221.38 | Buy |
| 20-day EMA: | 221.24 | Buy |
| 50-day EMA: | 213.08 | Buy |
| 200-day EMA: | 139.65 | Buy |
Cidara Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.64 | Buy |
| Relative Strength Index (14 RSI): | 84.21 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (221.38 - 221.38) | Sell |
| Bollinger Bands (100): | (130.05 - 238.71) | Buy |
Cidara Therapeutics, Inc. Technical Analysis
| Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 11 | 12 | 13 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cidara Therapeutics, Inc. Stock
Is Cidara Therapeutics, Inc. Stock a Buy?
-
Cidara Therapeutics, Inc. share price is 221.38 while CDTX 8-day simple moving average is 221.38, which is a Sell signal.
-
The stock price of CDTX is 221.38 while Cidara Therapeutics, Inc. 20-day SMA is 221.38, which makes it a Sell.
-
Cidara Therapeutics, Inc. 50-day simple moving average is 221.17 while CDTX share price is 221.38, making it a Buy technically.
-
CDTX stock price is 221.38 and Cidara Therapeutics, Inc. 200-day simple moving average is 117.90, creating a Buy signal.
CDTX Technical Analysis vs Fundamental Analysis
Buy
64
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. a Buy or a Sell?
-
Cidara Therapeutics, Inc. stock is rated a BuyThe current Cidara Therapeutics, Inc. [CDTX] share price is $221.38. The Score for CDTX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
Cidara Therapeutics, Inc. Stock Info
Market Cap:
7B
Price in USD:
221.38
Share Volume:
0
Cidara Therapeutics, Inc. 52-Week Range
52-Week High:
221.42
52-Week Low:
15.22
Buy
64
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Cidara Therapeutics, Inc. Share Price Forecast
-
What is the Cidara Therapeutics, Inc. stock price today?The Cidara Therapeutics, Inc. stock price is 221.38 USD today.
-
Will CDTX stock go up or go down?Cidara Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Cidara Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cidara Therapeutics, Inc. is not overvalued.
Is Cidara Therapeutics, Inc. Stock a Buy?
-
Cidara Therapeutics, Inc. share price is 221.38 while CDTX 8-day exponential moving average is 221.38, which is a Buy signal.
-
The stock price of CDTX is 221.38 while Cidara Therapeutics, Inc. 20-day EMA is 221.24, which makes it a Buy.
-
Cidara Therapeutics, Inc. 50-day exponential moving average is 213.08 while CDTX share price is 221.38, making it a Buy technically.
-
CDTX stock price is 221.38 and Cidara Therapeutics, Inc. 200-day simple moving average is 139.65, creating a Buy signal.
Fundamental Analysis of Cidara Therapeutics, Inc.
Is Cidara Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and an increase next year of $0.59 per share.
Technical Analysis of Cidara Therapeutics, Inc.
Should I short Cidara Therapeutics, Inc. stock?
-
CDTX Moving Average Covergence Divergence (MACD) indicator is 0.64, suggesting Cidara Therapeutics, Inc. is a Buy
-
Cidara Therapeutics, Inc. Relative Strength Index (RSI) is 84.21, which suggest Cidara Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Cidara Therapeutics, Inc. is (221.38 - 221.38), which suggest Cidara Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Cidara Therapeutics, Inc. is (130.05 - 238.71), which suggest Cidara Therapeutics, Inc. is a Buy
* Cidara Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.